As the exclusive distributor of the products in Germany, Dr.
Reddy’s, this launch strengthens its presence in the growing German medical cannabis market, a presence already strengthened since the company’s recent acquisition of Nimbus Health GmbH, specializing in the distribution, registration, sale and the commercialization of therapeutic cannabis.
Reddy’s and MediCane have also signed an agreement to co-fund a Phase II clinical trial of a cannabis-based product for the relief of behavioral and psychological symptoms of dementia .